157 related articles for article (PubMed ID: 9045680)
1. Structure of recombinant human CPP32 in complex with the tetrapeptide acetyl-Asp-Val-Ala-Asp fluoromethyl ketone.
Mittl PR; Di Marco S; Krebs JF; Bai X; Karanewsky DS; Priestle JP; Tomaselli KJ; Grütter MG
J Biol Chem; 1997 Mar; 272(10):6539-47. PubMed ID: 9045680
[TBL] [Abstract][Full Text] [Related]
2. Processing/activation of CPP32-like proteases is involved in transforming growth factor beta1-induced apoptosis in rat hepatocytes.
Inayat-Hussain SH; Couet C; Cohen GM; Cain K
Hepatology; 1997 Jun; 25(6):1516-26. PubMed ID: 9185777
[TBL] [Abstract][Full Text] [Related]
3. A DEVD-inhibited caspase other than CPP32 is involved in the commitment of cerebellar granule neurons to apoptosis induced by K+ deprivation.
D'Mello SR; Aglieco F; Roberts MR; Borodezt K; Haycock JW
J Neurochem; 1998 May; 70(5):1809-18. PubMed ID: 9572264
[TBL] [Abstract][Full Text] [Related]
4. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease.
Cryns VL; Bergeron L; Zhu H; Li H; Yuan J
J Biol Chem; 1996 Dec; 271(49):31277-82. PubMed ID: 8940132
[TBL] [Abstract][Full Text] [Related]
5. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.
Slee EA; Zhu H; Chow SC; MacFarlane M; Nicholson DW; Cohen GM
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):21-4. PubMed ID: 8670109
[TBL] [Abstract][Full Text] [Related]
6. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis.
Rotonda J; Nicholson DW; Fazil KM; Gallant M; Gareau Y; Labelle M; Peterson EP; Rasper DM; Ruel R; Vaillancourt JP; Thornberry NA; Becker JW
Nat Struct Biol; 1996 Jul; 3(7):619-25. PubMed ID: 8673606
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
8. The apoptotic cysteine protease CPP32.
Kumar S
Int J Biochem Cell Biol; 1997 Mar; 29(3):393-6. PubMed ID: 9202418
[TBL] [Abstract][Full Text] [Related]
9. Involvement of ICE (Caspase) family in gamma-radiation-induced apoptosis of normal B lymphocytes.
Hallan E; Blomhoff HK; Smeland EB; Lømo J
Scand J Immunol; 1997 Dec; 46(6):601-8. PubMed ID: 9420624
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the tertiary structure and substrate binding site of caspase-8.
Chou KC; Jones D; Heinrikson RL
FEBS Lett; 1997 Dec; 419(1):49-54. PubMed ID: 9426218
[TBL] [Abstract][Full Text] [Related]
11. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.
Enari M; Talanian RV; Wong WW; Nagata S
Nature; 1996 Apr; 380(6576):723-6. PubMed ID: 8614469
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of rabbit CPP32 and its function in vascular smooth muscle cell apoptosis.
Wang H; Keiser JA
Am J Physiol; 1998 Apr; 274(4):H1132-40. PubMed ID: 9575916
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.
Hara H; Friedlander RM; Gagliardini V; Ayata C; Fink K; Huang Z; Shimizu-Sasamata M; Yuan J; Moskowitz MA
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2007-12. PubMed ID: 9050895
[TBL] [Abstract][Full Text] [Related]
14. Need for caspases in apoptosis of trophic factor-deprived PC12 cells.
Haviv R; Lindenboim L; Li H; Yuan J; Stein R
J Neurosci Res; 1997 Oct; 50(1):69-80. PubMed ID: 9379495
[TBL] [Abstract][Full Text] [Related]
15. The atomic-resolution structure of human caspase-8, a key activator of apoptosis.
Watt W; Koeplinger KA; Mildner AM; Heinrikson RL; Tomasselli AG; Watenpaugh KD
Structure; 1999 Sep; 7(9):1135-43. PubMed ID: 10508785
[TBL] [Abstract][Full Text] [Related]
16. Mch3, a novel human apoptotic cysteine protease highly related to CPP32.
Fernandes-Alnemri T; Takahashi A; Armstrong R; Krebs J; Fritz L; Tomaselli KJ; Wang L; Yu Z; Croce CM; Salveson G
Cancer Res; 1995 Dec; 55(24):6045-52. PubMed ID: 8521391
[TBL] [Abstract][Full Text] [Related]
17. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases.
Shimizu T; Pommier Y
Leukemia; 1997 Aug; 11(8):1238-44. PubMed ID: 9264376
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the tertiary structure of a caspase-9/inhibitor complex.
Chou KC; Tomasselli AG; Heinrikson RL
FEBS Lett; 2000 Mar; 470(3):249-56. PubMed ID: 10745077
[TBL] [Abstract][Full Text] [Related]
19. Processing/activation of at least four interleukin-1beta converting enzyme-like proteases occurs during the execution phase of apoptosis in human monocytic tumor cells.
MacFarlane M; Cain K; Sun XM; Alnemri ES; Cohen GM
J Cell Biol; 1997 Apr; 137(2):469-79. PubMed ID: 9128256
[TBL] [Abstract][Full Text] [Related]
20. Caspases (interleukin-1beta-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts.
Okahashi N; Koide M; Jimi E; Suda T; Nishihara T
Bone; 1998 Jul; 23(1):33-41. PubMed ID: 9662128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
